ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

Governor Brown Signs CLSA-Sponsored Bill into Law to Protect Diabetes Patients
Facebook
Twitter
LinkedIn

August 19, 2017

Assembly Bill 602 (Bonta), a bill sponsored by CLSA, was recently signed into law by Governor Jerry Brown. The law, which is already in effect due to an urgency clause, prohibits pharmacies from submitting insurance claims for diabetes test devices, such as blood glucose testing strips, acquired from unauthorized distributors.

The goal of the law is to protect patients from diabetic testing supplies that have left the controlled supply chain and may consequently be faulty due to improper storage, as well as potentially counterfeit. The law will also help protect health insurers from fraudulent insurance claims for devices that are intended for the international market and those that have already been dispensed to consumers and repurchased and re-dispensed to new consumers.

SB 602 will also grant the Board of Pharmacy authority to make it “unprofessional conduct” to acquire prescription diabetes test devices from someone the licensee knows, or should have known, was not the manufacturer or authorized distributor. It also authorizes a Board inspector to embargo nonprescription diabetes test devices that were not purchased directly from an authorized distributor or manufacturer.

The author of the bill, Assemblymember Rob Bonta (D-Alameda), thanked CLSA for sponsoring the measure and commented on the merits of AB 602, stating: “Blood glucose monitors and test strips are an essential tool for patients and their physicians to measure and treat diabetes. Unfortunately, these products have also become the basis for millions in fraudulently submitted claims. AB 602 will target these abuses, preventing cost increases, and maintaining affordable, high-quality testing products for the patients who use these test strips daily. I’m very proud to author this bill and thank the California Life Sciences Association (CLSA) and the innovative life sciences companies they represent for leading the effort in support of AB 602.”

CLSA looks forward to working with our members in the diabetic testing supplies market and the Board of Pharmacy to ensure the law is successfully implemented going forward in a way that ensures patients can rely on testing strips and other supplies purchased at California pharmacies.

Click here to view CLSA’s press release applauding Gov. Brown on signing the bill. Questions? Please contact Brett Johnson, CLSA’s Senior Director, Policy & Regulatory Affairs (BJohnson@califesciences.org).